IKOS CIF’s Zimmer Biomet ZBH Stock Holding History

IKOS CIF’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,272	Closed	-$135K	–	298
2015 Q2	$135K	Buy	+1,272	New	+$141K	0.44%	103
2015 Q1	–	Sell	-241	Closed	-$27K	–	315
2014 Q4	$27K	Sell	241 -3,073	-93%	-$324K	0.05%	216
2014 Q3	$326K	Buy	+3,314	New	+$326K	0.47%	95
2014 Q2	–	Sell	-1,880	Closed	-$174K	–	292
2014 Q1	$174K	Buy	+1,880	New	+$173K	0.26%	114
2013 Q3	–	Sell	-4,844	Closed	-$353K	–	275
2013 Q2	$353K	Buy	+4,844	New	+$362K	0.66%	56

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

IKOS CIF's ZBH Position: Q3 2015 in Review

IKOS CIF sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 1,272 shares — an estimated $135K sold.

IKOS CIF first reported a position in ZBH in Q2 2013 and held it in 5 quarters. The position peaked at $353K in Q2 2013. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

IKOS CIF reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
IKOS CIF sold 1,272 Zimmer Biomet shares in Q3 2015, an estimated $135K.
IKOS CIF first reported a position in Zimmer Biomet in Q2 2013 and held it in 5 quarters.
IKOS CIF's Zimmer Biomet position peaked at $353K in Q2 2013.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on IKOS CIF's 13F filing for Q3 2015, filed 13 Nov 2015.